Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Must Reads In FDA Actions
FDA Actions for March/April 2017
FDA Approves Noctiva for Frequent Urination, FDA news release; 2017 Mar 3
FDA Expands Approval of Spiriva Respimat for Children , Boehringer Ingelheim news release; 2017 Feb 16
FDA Actions for January/February 2017
FDA Approves Symbicort for Pediatric Asthma, AstraZeneca news release; 2017 Jan 30
FDA Approves RespiClick Maintenance Inhalers for Asthma, Teva Pharmaceutical news release; 2017 Jan 30
FDA Approves Trulance for Chronic Idiopathic Constipation, FDA news release; 2017 Jan 19
FDA Actions for November/December 2016
FDA Approves Synjardy XR for Adults with T2D, Eli Lilly news release; 2016 Dec 12
FDA Approves Eucrisa for Eczema, FDA news release; 2016 Dec 14
FDA Approves Jardiance for CV Mortality Indication, FDA news release; 2016 Dec 2
FDA Approves Intrarosa for Treatment of Dyspareunia, FDA news release; 2016 Nov 17
FDA Approves Xultophy 100/3.6 for Adults with T2D, Novo Nordisk news release; 2016 Nov 21
FDA Actions for September/October 2016
FDA Warns Against Use of Homeopathic Teething Tablets, FDA press release; 2016 Sep 30
FDA Approves Invokamet XR for Treatment of T2D, Janssen Pharmaceuticals news release; 2016 Sep 21
FDA Issues Final Rule on Antibacterial Soaps, FDA news release; 2016 Sep 2
FDA Warns of Combined Opioid Product Use, FDA news release; 2016 Aug 31
FDA Actions for July/August 2016
FDA Updates Fluoroquinolone Antibiotics Warnings, FDA news release; 2016 Jul 26